Blog

Class I

Many Class I medical devices aren’t what a lot of people would consider medical devices. A motor-less toothbrush or a callus remover could be considered a Class I device. These devices are subject to the least strict FDA controls. General controls require a mandatory recall if the device is found to be defective, among other controls.

Class II

Examples of class II medical devices might be a motorized wheelchair or an over the counter blood pressure monitor. Class II devices are subject to special controls, as well as all general controls. Special controls would require certain guidelines and performance standards, as well as special labeling requirements on how to use the product safely and effectively.

Class III

A Class III medical device is the highest class device and applies to devices like medical implants. Class III medical devices are subject to general controls and must have premarket approval by the FDA before market placement and use by hospitals or doctors. This class is the most involved and requires a great deal of work back and forth with the FDA.

When to Contact an FDA Medical Device Lawyer

Any time you are manufacturing a medical device, it’s important to consult with a lawyer regarding classification and registration. Therefore, to ensure your device is approved for market, make sure you have everything in order for the FDA.

Many companies and entrepreneurs are intimidated by the requirements of the FDA, whether they face general controls, general controls and special controls, or general controls and premarket approval. At the Capote Law Firm, we can help you navigate the challenges set forth by the FDA. Ultimately, this can help you get your medical device on the market, so you can grow your business.

Call today for a consultation to discuss your legal options.

The FDA is planning to update the regulations regarding nutrient content and health claims to conform to the updated nutrition labeling regulations published in May, 2016.

FDA’s Guidance announces that it intends to exercise enforcement discretion for products labeled as “healthy” that are not low in total fat, if the fat predominantly consists of unsaturated fats, and if the nutrition facts box declares the amounts of the poly and mono unsaturated fats. In addition, FDA intends to exercise enforcement discretion when the food contains less than ten percent of the Daily Value (DV) per reference amount customarily consumed (RACC) of vitamin A, vitamin C, calcium, iron, protein, and fiber, but the food contains at least 10% of the DV per RACC of vitamin D or potassium. For labels that do not use the updated nutrition facts panel, the manufacturer may use the old DVs. If a manufacturer uses the updated nutrition facts panel, the updated DVs for potassium and vitamin D must be used. In addition, the relevant nutrient(s) must be declared in the nutrition facts box. FDA stated, “it that it may take some time, but we want to get it right”

Currently the update of the labels is voluntary, this until 26 July 2018 or 26 July 2019 for companies with sales under $10 million. Further the FDA plans to issue new regulations in regards to the annual sales of food.

The quality of the graphics is much better (See 21 C.F.R. §§ 101.9 and 101.36), also the FDA includes a scale model of the Nutritional Information where it represents the format, the thickness of the lines, font and the main specifications which were previously contained in appendix B of 21 C.F.R. Part 101.
The FDA has responded questions however replied that additional guides for more specifics will be later developed.

Actualmente la actualización de las etiquetas es voluntaria, ésto hasta el 26 Julio del 2018 ó 26 de Julio del 2019 para compañías con ventas menores a los 10 millones de dólares. Más Adelante la FDA planea emitir nuevas normativas determinativas con respecto a las ventas anuales de comida.

La calidad de los gráficos es mucho mejor (Ver 21 C.F.R. §§ 101,9 y 101.36), también la FDA incluye una maqueta de la Información Nutricional donde se representa el formato, grosor de las líneas, forma de la letra y las principales especificaciones que antes figuraban en el Apendice B de 21 C.F.R. Parte 101.

La FDA ha respondido muchas preguntas sin embargo informa que mas adelante elaborará otras guías para consultas.

The products containing meat, chicken or egg as a main ingredient do not need to comply with GMO labeling requirements.

The USDA Agricultural Marketing Service is required to set its regulations within of two years after promulgation of the legislation. USDA will be responsible for determining the origin of the bioengineering and establish the process for classifying the manufacturers such as either “manufacturers of small meals” or ”food manufacturers very small.” The latter would be exempt from GMO labeling.

USDA will need to provide disclosure options, such as a symbol or a QR code or a toll free number to put consumers on notice of GMO declaration.

Capote Law Firm is proud to announce our partner Lisa Capote has received a Martindale Hubbell AV Preeminent rating. Martindale Hubbell’s peer review rating is based on five key areas: legal knowledge, analytical capabilities, judgment, communication ability and legal experience. AV Preeminent is the highest rating available.

As of June 1, 2009, FDA no longer accepts FDA registrations for OTC drugs specifically, drug establishment registration and drug listing information in paper format unless FDA grants a waiver which must be accompanying with a reason as to why the company cannot conduct its FDA registration via the internet.

Domestic and foreign establishments that manufacture, repack, or re-label drug products in the United States are required to obtain FDA registration. Domestic and foreign drug manufacturers, repackers or re-labelers are also required to list all of their commercially marketed drug products. This information helps the FDA maintain a catalog of all drugs in commercial distribution in the United States. Drug products that are not properly listed as required are misbranded and may be subject to regulatory action.

Foreign establishments that manufacture, repack, or re-label drug products and import or offer for import drug products to the United States must obtain FDA registration from their OTC drugs and identify a U.S. agent. All drugs imported into the United States must be listed by the foreign firm or its designated U.S. agent prior to importation. Any OTC drugs that arrive to the US border without the necessary labeler codes, establishment registration or drug listings will not be permitted into the US.

The FDA relies on registration, listing, and U. S. agent information for administering many key programs, including postmarketing surveillance; user fee assessments; counterterrorism; monitoring of drug shortages and availability; and determining products that are being marketed without an approved application.

The new FDA registration online system requires many preliminary steps to ensure that the submitting company knows how to work the system and in fact has the authority to file the submissions on behalf of the company. Many companies do not have their FDA registrations simply because the company’s individuals do not understand the online system. Arrastia, Capote & Phang conducts the entire process from start to finish with minimal work on their client’s part, ensuring labeler codes, establishment registrations and NDC numbers are issued.

How Does FDA Identify a High-Risk (HR) Facility?

The agency is utilizing a decision-making process based on the risk factors identified in section 421(a)(1) of the FD&C Act, which are:

1. The known safety risks of the food manufactured, processed, packed, or held at the facility;
2. The compliance history of a facility, including with regard to food recalls, outbreaks of foodborne illness, and violations of food safety standards;
3. The rigor and effectiveness of the facility’s hazard analysis and risk-based preventive controls;
4. Whether the food manufactured, processed, packed or held at the facility meets the criteria for priority under section 801(h)(1) of the FD&C Act, which relates to the prioritization to detect intentional adulteration in food offered for import into the U.S.;
5. Whether the food or the facility that manufactured, processed, packed, or held such food has received a certification as described in section 801(q) (concerning imported food) or 806 (voluntary qualified importer program) of the FD&C Act, as appropriate;
6. Any other criteria deemed necessary and appropriate by the Secretary for purposes of allocating inspection resources.

For the FY 2011-13 planning cycle for domestic facilities, the decision-making process is based primarily on the first two factors listed, as well as certain additional criteria identified as part of the sixth factor. There are not data available at this time to characterize the third factor for all industry types. It will be incorporated as the Preventive Controls regulation and the data collection develop. The fourth factor applies only to foreign facilities. While the fifth factor may apply to some domestic facilities, the relevant certification programs have not yet been established.

Two additional factors that have been identified pursuant to the sixth item are: establishment type / type of activity conducted at the facility (manufacturer/processor, repacker/packer, etc.) and years since last inspection.

The method utilized is through a software program that assesses the characteristics of each facility in the agency’s inventory. SAS® software provides data access, analysis, and reporting from the agency’s internal data systems. The current model is best depicted with a decision tree as shown in Diagram 1 resulting in facilities being categorized as HR or NHR.

Identification of HR facilities is based on the known safety risks of foods at the industry-wide level and compliance history, which is firm specific.

• The “known safety risks” of food are based on broad, industry-level food commodity categories, e.g., bakery, leafy vegetables, spices. If a facility manufactures food commodity categories associated with foodborne outbreaks AND class I recalls, then they are placed in the HR facility category. If a facility manufactures food commodities associated with foodborne outbreaks OR class I recalls and they have not been inspected within the previous five fiscal years, then they are placed in the HR facility category.
• The facility-specific factor of “compliance history” is based on inspection results for a facility from the previous five fiscal years. Facilities with a history of non-compliance with food safety requirements (a history of three or more VAI within the five year time period) and those with food safety violations of regulatory significance (one or more OAI in the five year time period) are placed in the HR facility category.

Under the proposed FDA law, FDA officials that have a reasonable belief that an article or any other food that may be affected in a similar manner will be permitted access to records to pertaining to these food products.

Under the current FDA law, an FDA official may request records of a specific food product where there is reason to believe it is adulterated. The new regulations will expand FDA’s powers to review records. As an example, an importer of papaya from Mexico will automatically be detained under an Import Alert currently in place. If in the same container a different fruit, say mangos, are being shipped there is the potential that FDA officials “reasonably believe” the mangos, simply for being shipped with the papayas, can be adulterated. At that point, FDA can request documentation from the importer or supplier to confirm the status and safety of the product. The FDA law requires that these documents must be made available as soon as possible, but not to exceed 24 hours from the time of receipt of the request.

Although the new FDA law is only a proposed law, there is a potential it will become regulation after the prescribed notice and comment period. Importers and suppliers, alike, need to be prepared to turn over any and all documentation related to their food products on a moment’s notice that establishes the safety of the product.